niacin [clinicaltrials_resource:f3b10d3bf12735c36b712c4d9226f382]
Harvard Atherosclerosis Reversibility Project (HARP) [clinicaltrials:NCT00000461]Coronary Drug Project [clinicaltrials:NCT00000482]Coronary Drug Project Mortality Surveillance [clinicaltrials:NCT00000483]Arterial Disease Multifactorial Intervention Trial (ADMIT) [clinicaltrials:NCT00000539]HDL-Atherosclerosis Treatment Study (HATS) [clinicaltrials:NCT00000553]Cholesterol-Lowering Atherosclerosis Study (CLAS) [clinicaltrials:NCT00000599]Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia [clinicaltrials:NCT00304993]
intervention [clinicaltrials_vocabulary:intervention]
niacin [clinicaltrials_resource:f3b10d3bf12735c36b712c4d9226f382]
Bio2RDF identifier
f3b10d3bf12735c36b712c4d9226f382
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f3b10d3bf12735c36b712c4d9226f382
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:f3b10d3bf12735c36b712c4d9226f382
title
niacin
@en
type
label
niacin [clinicaltrials_resource:f3b10d3bf12735c36b712c4d9226f382]
@en